EUVIMEDEUVIMED entdecken
Crossref

Glabridin mitigates osteoarthritis progression through modulation of the PI3K/AKT/FOXO3A autophagy axis

Linbing Lou, Zhu Zhu, Lei Xu, Zhimin Wu, Xiaofei Wang, Luqi Yuan, Haixiang Miao, Cunyi Xia, Jihang Dai

Phytomedicine · 2025-11 · 148 · 157359

DOI: 10.1016/j.phymed.2025.157359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025-11. Verfasst von Linbing Lou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, 225001, China. Hauptthemen laut MEDLINE: Isoflavones, Osteoarthritis, Forkhead Box Protein O3, Autophagy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Science and Technology Support Program of Jiangsu Province, Postdoctoral Research Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Osteoarthritis (OA) is a common degenerative joint disorder marked by the breakdown of cartilage and disrupted cellular balance. While Glabridin (Gla) has shown properties that are anti-inflammatory and antioxidant, the exact therapeutic mechanism of Gla in the context of OA is not well understood. The goal of this study is to pinpoint and validate the key molecular pathway through which Gla provides protection against the advancement of OA. OBJECTIVE: This study aims to investigate the molecular mechanisms by which Gla regulates extracellular matrix (ECM) metabolism in chondrocytes, revealing critical targets and signaling pathways that mediate its therapeutic impact on osteoarthritis (OA) progression. METHODS: We used a multi-faceted approach, beginning with an integrated analysis of network pharmacology and RNA sequencing to predict Gla's key molecular targets and signaling pathways. We then performed molecular docking and surface plasmon resonance (SPR) to validate a direct physical interaction between Gla and FOXO3A. The functional consequences were confirmed in human chondrocytes using qPCR, Western blotting, immunofluorescence, and an autophagic flux reporter. We established the central role of FOXO3A by demonstrating that its siRNA-mediated knockdown abolishes Gla's effects. Finally, we assessed Gla's therapeutic efficacy in a mouse model of ACLT-induced OA using histological staining and OARSI scoring. RESULTS: Our results indicate that Gla mitigates IL-1β-induced ECM degradation by modulating the PI3K/AKT/FOXO3A axis. Gla directly binds FOXO3A, promoting its dephosphorylation and nuclear translocation to activate autophagy-related genes. Local administration of Gla significantly attenuated OA progression in vivo, as reflected by reduced cartilage degeneration and improved OARSI scores. Inhibition of autophagy with 3-MA exacerbated OA pathology, an effect partially reversed by Gla. CONCLUSION: Our study demonstrates that Gla protects chondrocytes and attenuates OA progression by directly targeting FOXO3A and activating the autophagy pathway. This mechanism highlights the potential of Gla as a novel disease-modifying agent for osteoarthritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoflavonesOsteoarthritisForkhead Box Protein O3AutophagyPhenolsAnimalsHumansChondrocytesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesSignal TransductionMiceMaleMice, Inbred C57BLMolecular Docking SimulationDisease ProgressionExtracellular MatrixDisease Models, Animal

Stichwörter der Autor:innen

AutophagyFOXO3AGlabridin (Gla)Osteoarthritis (OA)

Substanzen

IsoflavonesForkhead Box Protein O3glabridinProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesPhenolsFOXO3 protein, human

Autor:innen und Institutionen

  • Department of Orthopedics, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, 225001, China.
  • Department of Orthopedics, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, 225001, China; Dalian Medical University, Dalian, Liaoning, 116000, China.
  • Yangzhou Hospital of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Dalian Medical University, Dalian, Liaoning, 116000, China.
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.
  • Department of Orthopedics, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, 225001, China. Electronic address: daijihang@yzu.edu.cn.

Förderung

  • Science and Technology Support Program of Jiangsu Province
  • Postdoctoral Research Foundation of China
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Lou, L., Zhu, Z., Xu, L., Wu, Z., Wang, X., Yuan, L., Miao, H., Xia, C., & Dai, J. (2025). Glabridin mitigates osteoarthritis progression through modulation of the PI3K/AKT/FOXO3A autophagy axis. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157359

Vancouver

Lou L, Zhu Z, Xu L, Wu Z, Wang X, Yuan L, et al. Glabridin mitigates osteoarthritis progression through modulation of the PI3K/AKT/FOXO3A autophagy axis. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157359

BibTeX
@article{Lou2025,
  author = {Lou, Linbing and Zhu, Zhu and Xu, Lei and Wu, Zhimin and Wang, Xiaofei and Yuan, Luqi and Miao, Haixiang and Xia, Cunyi and Dai, Jihang},
  title = {Glabridin mitigates osteoarthritis progression through modulation of the PI3K/AKT/FOXO3A autophagy axis},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2025.157359}
}
Kostenlos starten →